AIG
RLAY icon

American International Group’s Relay Therapeutics RLAY Stock Holding History

American International Group’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-46,686
Closed -$387K – 2153
2024
Q1 		$387K Buy
46,686
+1,810
+4% +$17.7K ﹤0.01% 1783
2023
Q4 		$494K Sell
44,876
-181
-0.4% -$1.53K ﹤0.01% 1670
2023
Q3 		$379K Buy
45,057
+1,602
+4% +$17.2K ﹤0.01% 1761
2023
Q2 		$546K Buy
43,455
+2,374
+6% +$29.5K ﹤0.01% 1592
2023
Q1 		$677K Buy
41,081
+818
+2% +$14.7K ﹤0.01% 1433
2022
Q4 		$602K Buy
40,263
+3,944
+11% +$75.5K ﹤0.01% 1493
2022
Q3 		$812K Buy
36,319
+512
+1% +$11.2K 0.01% 1293
2022
Q2 		$600K Buy
35,807
+1,069
+3% +$22.9K ﹤0.01% 1490
2022
Q1 		$1.04M Sell
34,738
-2,446
-7% -$59.3K 0.01% 1314
2021
Q4 		$1.14M Buy
37,184
+4,328
+13% +$137K 0.01% 1348
2021
Q3 		$1.04M Buy
32,856
+53
+0.2% +$1.78K 0.01% 1433
2021
Q2 		$1.2K Buy
32,803
+6,078
+23% +$200K ﹤0.01% 1418
2021
Q1 		$924 Buy
26,725
+8,016
+43% +$348K ﹤0.01% 1500
2020
Q4 		$778 Sell
18,709
-536
-3% -$24.2K ﹤0.01% 1527
2020
Q3 		$820K Buy
+19,245
New +$734K ﹤0.01% 1345

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

American International Group's RLAY Position: Q2 2024 in Review

American International Group sold out of Relay Therapeutics (RLAY) in Q2 2024, closing a stake of 46,686 shares — an estimated $387K sold.

American International Group first reported a position in RLAY in Q3 2020 and held it in 15 quarters. The position peaked at $1.14M in Q4 2021. 178 funds tracked by Wall St. Rank hold RLAY as of Q2 2024.

  • American International Group reported no remaining Relay Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 46,686 Relay Therapeutics shares in Q2 2024, an estimated $387K.
  • American International Group first reported a position in Relay Therapeutics in Q3 2020 and held it in 15 quarters.
  • American International Group's Relay Therapeutics position peaked at $1.14M in Q4 2021.
  • 178 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.